In 2016, CTS tested more source plasma samples (4.9 million) than blood donor samples (4.5 million)
Transitioned all 5 CTS labs from an investigational new drug (IND) to a licensed pooled Babesia test...
In August CTS begins source plasma testing as a new line of business to one of the largest plasma fr...
By the end of 2017, CTS has secured three source plasma partners and continues to seek additional pa...
CTS Tampa lab implemented the Ortho Clinical Diagnostics VITROSĀ® testing platform to perform COVID-1...
In January, CTS is incorporated as a non-profit organization owned by Vitalant and OneBlood (formerl...
CTS merges with the three Red Cross testing laboratories located in Charlotte, Portland and St. Loui...